The ESTRO Elections 2026 are officially underway, with voting open from 7 April to 7 May 2026. This pivotal moment for the European Society for Radiotherapy and Oncology invites members to shape the Society’s future by electing its next President-Elect and Board Members.
As part of the election process, the President-Elect candidates have shared their vision in short, 30-second video reflections, outlining the impact they aim to make and how they plan to advance ESTRO’s mission for both patients and professionals.
Hans Langendijk
University Medical Center Groningen & University of Groningen, Groningen, The Netherlands
” Success means ESTRO is leading a future, where radiotherapy is efficient, evidence – driven, and integrated into modern cancer care. It is also about using AI supported decisions, harmonized standards, using real-world data to accelerate innovation and fostering multidisciplinary colloration so every patient receives high value personalized treatment.”
Carmen Rubio Rodríguez
HM Hospitales & Clara Campal Cancer Center & Camilo José Cela University, Madrid, Spain
” I do believe that success will mean that ESMO becomes a truly united and influential community where every professional feels valued and connected and where knowledge moves faster from innovation to patient care. Success will also mean that that radiotherapy is fully recognised as a cornerstone of cancer care across Europe. And above all, success will show what matters most, more equitable access, better care and better outcomes for patients.”
Voting will take place through a secure, secret electronic ballot sent directly to eligible members’ inboxes. Elections are decided by a simple majority of valid votes cast.
ESTRO Elections 2026: Who Will Lead the Future of Radiation Oncology?
Written by Nare Hovhannisyan, MD